Pelago Bioscience AB - Company Review
Pelago Bioscience AB - Company ReviewSummary
Pelago Bioscience AB (Pelago Bioscience) is a life science contract research organization which offers target engagement measurements of small molecule compounds on target proteins. It utilizes patented Cellular Thermal Shift Assay (CETSA) technology to enable direct, in situ physiologically relevant measurements of target engagement on target proteins in lysate, intact cells and tissue samples. Pelago Bioscience delivers in situ target engagement studies to accelerate the preclinical and clinical drug discovery and diagnostics development. It also works in partnership with other organizations which enables them to utilize the CETSA technology. The organization is a spun out from the Karolinska Institute, Stockholm, Sweden. Pelago Bioscience is headquartered in Solna, Sweden.
This comprehensive company report of Pelago Bioscience AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.